{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:37:42Z","timestamp":1786991862152,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jconrel.2017.03.039","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T16:33:00Z","timestamp":1490286780000},"page":"10-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats"],"prefix":"10.1016","volume":"254","author":[{"given":"Mohamed O.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira H.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.03.039_bb0005","first-page":"1","article-title":"Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review","author":"Hsiao","year":"2016","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12872-016-0324-1","article-title":"The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model","volume":"16","author":"Zhou","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0015","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003088-200342130-00005","article-title":"Clinical pharmacokinetics of atorvastatin","volume":"42","author":"Lennern\u00e4s","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1124\/dmd.105.009076","article-title":"Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism","volume":"34","author":"Lau","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40264-016-0394-0","article-title":"Safety profile of atorvastatin 80 mg: a meta-analysis of 17 randomized controlled trials in 21, 910 participants","volume":"39","author":"Li","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0030","article-title":"Traversing the skin barrier through nano-emulsions","volume":"13","author":"Burger","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2016.07.027","article-title":"Nanocarriers for drug delivery into and through the skin - Do existing technologies match clinical challenges?","volume":"242","author":"Vogt","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.09.008","article-title":"Transdermal delivery from liposomal formulations - evolution of the technology over the last three decades","author":"Ashtikar","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0045","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejpb.2016.02.013","article-title":"Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline","volume":"102","author":"Al Shuwaili","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0055","first-page":"2431","article-title":"Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction","volume":"9","author":"Ali","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0060","article-title":"Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application","author":"Jain","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.03.008","article-title":"SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization","volume":"391","author":"Basalious","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2012.12.003","article-title":"Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy","volume":"441","author":"Subongkot","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0075","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2147\/DDDT.S103122","article-title":"Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluation","volume":"10","author":"Badr-Eldin","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2011.06.004","article-title":"Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan","volume":"8","author":"Ahad","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200342050-00004","article-title":"Transdermal drug delivery of insulin with ultradeformable carriers","volume":"42","author":"Cevc","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"El Zaafarany","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1081\/DDC-120025458","article-title":"Transfersomes\u2013a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation","volume":"29","author":"Jain","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0100","first-page":"61","article-title":"Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage","volume":"2004","author":"Cevc","year":"1663","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/10717544.2012.724472","article-title":"Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib","volume":"19","author":"Bragagni","year":"2012","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2006.04.016","article-title":"Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin","volume":"113","author":"Hiruta","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0115","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10717544.2014.902146","article-title":"Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study","volume":"22","author":"Khan","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/08982104.2012.700460","article-title":"Brain delivery of olanzapine by intranasal administration of transfersomal vesicles","volume":"22","author":"Salama","year":"2012","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1211\/jpp.58.9.0004","article-title":"Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin","volume":"58","author":"Shen","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0135","first-page":"1","article-title":"Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy","author":"Wang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0140","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1208\/s12249-015-0440-8","article-title":"Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery","volume":"17","author":"Aboud","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0378-5173(03)00268-0","article-title":"Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoinphotostability","volume":"260","author":"Manconi","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.colsurfa.2009.04.006","article-title":"Development and characterization of liposomes containing glycols as carriers for diclofenac","volume":"342","author":"Manconi","year":"2009","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/02652040802055411","article-title":"Vesicular aceclofenac systems: a comparative study between liposomes and niosomes","volume":"25","author":"Nasr","year":"2008","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0160","series-title":"Theory and Practice of Histological Techniques","first-page":"121","article-title":"The hematoxyline and eosin","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(01)00834-1","article-title":"Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis","volume":"229","author":"Johnston","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0170","first-page":"451","article-title":"A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies","volume":"55","author":"Zarghi","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2478\/intox-2013-0004","article-title":"Effect of poloxamer 407 administration on the serum lipids profile, anxiety level and protease activity in the heart and liver of mice","volume":"6","author":"Korolenko","year":"2013","journal-title":"Interdiscip. Toxicol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchromb.2005.06.035","volume":"827","author":"Mateos","year":"2005","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0190","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/10717541003667764","article-title":"Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation","volume":"17","author":"Sun","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(01)00576-2","article-title":"Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements","volume":"217","author":"Van den Bergh","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(00)00669-4","article-title":"In vitro skin permeation of estradiol from various proniosome formulations","volume":"215","author":"Fang","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0210","doi-asserted-by":"crossref","first-page":"418316","DOI":"10.1155\/2011\/418316","article-title":"Characterization and in vitro skin permeation of meloxicamloaded liposomes versus transfersomes","volume":"2011","author":"Duangjit","year":"2011","journal-title":"J Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1211\/0022357055515","article-title":"Tetanus toxoid-loaded transfersomes for topical immunization","volume":"57","author":"Gupta","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0220","series-title":"Application of Surface Activity in Therapeutics","author":"Srivastava","year":"2005"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0225","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3109\/10717544.2015.1013587","article-title":"Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation","volume":"23","author":"Aboud","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0230","first-page":"3865","article-title":"Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using d-optimal mixture design","volume":"10","author":"Yeom","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0235","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/03639045.2012.687745","article-title":"Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study","volume":"39","author":"Bandivadekar","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/08982104.2012.727422","article-title":"Development of a novel vesicular system using a binary mixture of sorbitanmonostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin","volume":"23","author":"Kamel","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0245","first-page":"283","article-title":"Development and characterization of nanoparticles of glibenclamide by solvent displacement method","volume":"67","author":"Dora","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0250","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1208\/ps020212","article-title":"Light scattering investigations on dilute nonionic oil-in-water microemulsions","volume":"2","author":"Warisnoicharoen","year":"2000","journal-title":"AAPS Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biomaterials.2004.02.020","article-title":"Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes","volume":"26","author":"Lee","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1208\/pt010431","article-title":"Novel mathematical method for quantitative expression of deviation from the Higuchi model","volume":"1","author":"Gohel","year":"2000","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0265","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1248\/cpb.49.1448","article-title":"Release from or through a wax matrix system. I. Basic release properties of the wax matrix system","volume":"49","author":"Yonezawa","year":"2001","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0939-6411(03)00021-3","article-title":"Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study","volume":"55","author":"Verma","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0169-409X(95)00091-K","article-title":"The skin: a pathway for systemic treatment with patches and lipid-based agent carriers","volume":"18","author":"Cevc","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0280","first-page":"1","article-title":"Utilizing Pluronic F-127 and Gelucire 50\/13 solid dispersions for enhanced skin delivery of flufenamic acid","author":"Shazly","year":"2012","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-3565(25)24258-6","article-title":"Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter","volume":"244","author":"Aungst","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0290","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00005344-200404000-00016","article-title":"The P-407\u2013induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date","volume":"43","author":"Johnston","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-511X-13-22","article-title":"Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of ATV and a cholesterol-rich diet","volume":"13","author":"Jim\u00e9nez-Santos","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jep.2015.12.004","article-title":"The hepatoprotective effect of the combination use of Fructus Schisandrae with statin \u2013 a preclinical evaluation","volume":"178","author":"Wat","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0305","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0310","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/archinte.161.22.2685","article-title":"Total cholesterol\/HDL cholesterol ratio vs LDL cholesterol\/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study","volume":"161","author":"Lemieux","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.fct.2015.05.016","article-title":"ATV induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase 12 dependent pathways","volume":"83","author":"Pal","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0320","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biochi.2015.02.016","article-title":"Protective effect of arjunolic acid against ATV induced hepatic and renal pathophysiology via MAPK, mitochondria and ER dependent pathways","volume":"112","author":"Pal","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151587","article-title":"High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort","volume":"11","author":"Clarke","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.03.039_bb0330","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08998280.2010.11928596","article-title":"Withholding statins in patients with underlying liver disease: wise or unwise?","volume":"23","author":"Perrillo","year":"2010","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0335","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/14740338.2010.495385","article-title":"ATV: safety and tolerability","volume":"9","author":"Athyros","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0340","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14740338.5.5.651","article-title":"Statins and myotoxicity: a therapeutic limitation","volume":"5","author":"Tiwari","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0345","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0350","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.foodchem.2011.05.036","article-title":"Nitric oxide (NO) scavenging capacity of natural antioxidants","volume":"129","author":"Sueishi","year":"2011","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0355","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0891-5849(02)01015-8","article-title":"Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide","volume":"33","author":"Stokes","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0365","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering\u2014are they clinically relevant?","volume":"24","author":"Bonettia","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0370","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mam.2008.08.003","article-title":"Glutathione in liver diseases and hepatotoxicity","volume":"30","author":"Yuan","year":"2009","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0375","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/0717-6287-47-5","article-title":"Selected spices and their combination modulate hypercholesterolemia-induced oxidative stress in experimental rats","volume":"47","author":"Otunola","year":"2014","journal-title":"Biol. Res."},{"key":"10.1016\/j.jconrel.2017.03.039_bb0380","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/eci.12642","article-title":"Increased thioredoxin levels are related to insulin resistance in familial combined hyperlipidaemia","volume":"46","author":"Martinez-Hervas","year":"2016","journal-title":"Eur. J. Clin. Investig."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916311452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916311452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:38:04Z","timestamp":1750163884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916311452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":76,"alternative-id":["S0168365916311452"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.039","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}